A new study suggests that babies are able to distinguish between the different objects they see around them at 2 months old, ...
The manufacturer's warranty isn't the be-all, end-all.
Jabalpur: Eighteen members of a Patel family from Narsinghpur district were hospitalised after allegedly consuming ...
Explore the latest strategies for selecting treatment regimens in HER2-positive breast cancer, focusing on safety and patient-specific factors. Treatment selection in HER2-positive breast cancer is ...
Forget about Herceptin. There’s a new HER2 agent that ought to be used in HER2-positive stomach cancer, and that’s Jazz Pharmaceuticals’ Ziihera. Or at least that appears to be the consensus following ...
The woman said her husband is “threatening divorce” because she’s going to a work event Latoya Gayle joined PEOPLE as an Associate Editor in 2024. Her work has previously appeared in The U.S. Sun, ...
Early and sustained clearance of circulating tumor DNA (ctDNA) was strongly associated with achieving pathologic complete response (pCR) in patients with early HER2-positive breast cancer receiving ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Forbes contributors publish independent expert analyses and insights. I’m a founder, writer and lecturer focusing on VC funds. BEIJING, CHINA - SEPTEMBER 24: A technician works in a lab at Sinovac ...
Function, a whole-body health company, announced it secured $298 million in an oversubscribed Series B round, boosting its valuation to $2.5 billion. Redpoint Ventures participated in the round, with ...
Following Priority Review, the U.S. FDA granted HYRNUO ® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results